53 studies found for:    metabolic syndrome | Open Studies | Interventional Studies | Adult | Phase 1, 2, 3 | Industry
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
Condition: Abdominal Obesity Metabolic Syndrome
Interventions: Drug: ALS-L1023;   Drug: placebo
2 Recruiting Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diastolic Dysfunction;   Insulin Resistance
Interventions: Behavioral: Lifestyle Counseling;   Drug: Metformin
3 Unknown  Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Conditions: Metabolic Syndrome;   Nonalcoholic Fatty Liver Disease
Intervention: Drug: Sodium Octanoate
4 Unknown  Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)
Condition: Metabolic Disease
Intervention: Dietary Supplement: LaFlavon
5 Recruiting Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Metabolic Syndrome
Interventions: Drug: Roflumilast;   Drug: Placebo
6 Recruiting Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Conditions: Gestational Diabetes Mellitus;   Type 2 Diabetes Mellitus;   Metabolic Syndrome;   Impaired Glucose Tolerance;   Disorder of Glucose Regulation
Interventions: Drug: Metformin XR plus placebo;   Drug: Metformin XR plus liraglutide
7 Recruiting A Parallel Study Evaluating the Effect of A-F Betafood® on Gallbladder and Liver Function.
Condition: Gallbladder
Intervention: Dietary Supplement: A-F Betafood
8 Recruiting Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)
Condition: Hepatitis C Virus Genotype 4 Infection
Interventions: Drug: Asunaprevir;   Drug: Daclatasvir;   Drug: Ribavirin;   Drug: Pegylated Interferon alpha-2a
9 Unknown  Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men
Conditions: Aging;   Obesity;   Insulin Resistance;   Hypogonadism
Intervention: Drug: Topical testosterone (Androgel) 10 g/day
10 Not yet recruiting Phase 2 Study of EPI-743 in Children With Pearson Syndrome
Condition: Pearson Syndrome
Intervention: Drug: EPI-743
11 Not yet recruiting PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
Conditions: Polycystic Ovary Syndrome (PCOS);   Insulin Resistance
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo metformin;   Drug: Placebo DLBS3233
12 Recruiting Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Condition: Nonmalignant Neoplasm
Interventions: Drug: treosulfan;   Drug: fludarabine phosphate;   Biological: anti-thymocyte globulin;   Radiation: total-body irradiation;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Drug: tacrolimus;   Drug: methotrexate;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Other: laboratory biomarker analysis
13 Recruiting Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome;   IBS
Interventions: Dietary Supplement: Bifidobacterium longum;   Other: Maltodextrin
14 Recruiting Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome (PCOS)
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo caplet of Metformin XR;   Drug: Placebo capsule of DLBS3233
15 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin (Leptin)
16 Recruiting The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome (CFS);   Myalgic Encephalomyelitis (ME)
Interventions: Drug: Methyl-P plus Nutrient Formula;   Drug: Methyl-P plus Nutrient matched placebos
17 Not yet recruiting Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
Condition: Glucose Transporter Type 1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
18 Recruiting Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Condition: Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Drug: Deferasirox placebo
19 Recruiting Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
Condition: Glut1 Deficiency Syndrome
Intervention: Drug: GLUT1 DS
20 Recruiting An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With MPS 7
Condition: Mucopolysaccharidosis Type 7
Intervention: Drug: UX003

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years